Cell Point
Cell Point (CELLPOINT) share price was ₹15.95 at the 28 Oct 2026 close; market capitalisation ₹29.80 Cr; P/E (TTM) 7.60; sector Retail. The share price fell 8.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue rose 11.7% year on year to ₹191 Cr and net profit was under ₹1 Cr, against ₹2 Cr a year earlier (compared with Mar 2025). Promoters held 73.06% of Cell Point in Jun 2026, unchanged from Mar 2026. Its Tapetide Score is 49/100 (Average) as of 28 Oct 2026.
Key Fundamentals
SMERetailConsumer ServicesPrice-based figures as of 28 Oct 2026, 13:23 IST · TTM
Peer Comparison
Consumer Discretionary › Retail › Speciality Retail
| ₹2,851.80 | 84.05 | 1,52,073 Cr | 21.77 | 0.14% | 24.22% | 28.23% | 21,061 Cr | 1,814 Cr | |
| ₹691.55 | 156.11 | 1,20,282 Cr | 13.76 | 0.00% | 5.66% | 7.21% | 9,825 Cr | 668 Cr | |
| ₹487.30 | 30.69 | 11,840 Cr | 6.03 | 1.63% | 25.86% | 27.76% | 1,426 Cr | 386 Cr | |
| ₹70.98 | 48.95 | 8,663 Cr | 6.13 | 0.67% | 12.11% | 13.23% | 8,682 Cr | 176 Cr | |
| ₹565.00 | 52.51 | 7,296 Cr | 10.60 | 0.22% | 16.98% | 21.70% | 2,934 Cr | 139 Cr | |
| ₹152.22 | 31.13 | 5,551 Cr | 6.15 | 0.00% | 17.96% | 20.64% | 3,470 Cr | 177 Cr | |
| ₹39.95 | — | 4,876 Cr | 0.83 | 0.00% | -13.25% | -3.16% | 8,673 Cr | -845 Cr | |
| Cell Point (this company) | ₹15.95 | 7.60 | 30 Cr | 0.40 | 1.56% | 0.09% | 6.99% | 148 Cr | 3 Cr |
| Median 8 companies | ₹319.76 | 48.95 | 7,980 Cr | 6.14 | 0.18% | 14.55% | 16.94% | 6,072 Cr | 177 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 100/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.38 times its book value
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 10.0% over past five years.
- Company has a low return on equity of 0.63% over last 3 years.
Technical Indicators
Oscillators
Bullish
Overall
Bullish
Moving Averages
Neutral
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 3.1% · Mar 2026
Quarterly Results
| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 147 | 158 | 163 | 154 | 171 | 177 | 191 |
| Expenses | 140 | 138 | 153 | 159 | 149 | 168 | 173 | 185 |
| Operating Profit | 9 | 9 | 5 | 4 | 5 | 3 | 4 | 6 |
| OPM % | 6% | 6% | 2.9% | 2.5% | 3% | 1.6% | 2.4% | 3.1% |
| Other Income | 1 | 1 | 2 | 0 | 1 | 3 | 0 | 0 |
| Interest | 4 | 5 | 3 | 2 | 2 | 3 | 3 | 4 |
| Depreciation | 0 | 1 | 0 | 2 | 3 | 0 | 1 | 2 |
| PBT | 5 | 4 | 2 | 0 | 0 | 2 | 0 | 1 |
| Tax % | 28% | 37% | 28% | 100% | 28% | 18% | 26% | 119% |
| Net Profit | 4 | 3 | 2 | 0 | 0 | 2 | 0 | 0 |
| EPS (₹) | 2.85 | 2.07 | 0.9 | 0.01 | 0.12 | 1.09 | 0.1 | -0.07 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 270 | 219 | 260 | 286 | 310 | 309 | 352 |
| Expenses | 261 | 211 | 249 | 268 | 301 | 302 | 342 |
| Operating Profit | 9 | 8 | 11 | 18 | 9 | 7 | 10 |
| OPM % | 3.5% | 3.6% | 4.2% | 6% | 2.8% | 2.4% | 2.9% |
| Other Income | 1 | 1 | 1 | 1 | 2 | 4 | 1 |
| Interest | 6 | 6 | 8 | 9 | 6 | 5 | 7 |
| Depreciation | 2 | 1 | 1 | 1 | 2 | 3 | 3 |
| PBT | 2 | 1 | 2 | 10 | 3 | 3 | 1 |
| Tax % | 33% | 46% | 32% | 32% | 38% | 20% | 94% |
| Net Profit | 2 | 1 | 2 | 7 | 2 | 2 | 0 |
| EPS (₹) | 1.17 | 0.5 | 1.2 | 4.93 | 0.9 | 1.21 | 0.03 |
| Div. Payout % | 0% | 0% | 0% | 0% | 28% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 19 | 19 | 19 |
| Reserves | 10 | 11 | 12 | 6 | 53 | 56 | 56 |
| Borrowings | 29 | 39 | 52 | 56 | 49 | 45 | 77 |
| Other Liabilities | 16 | 15 | 18 | 19 | 13 | 19 | 18 |
| Total Liabilities | 56 | 65 | 83 | 95 | 134 | 138 | 169 |
| Fixed Assets | 19 | 19 | 19 | 18 | 33 | 37 | 56 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 36 | 46 | 64 | 76 | 101 | 101 | 109 |
| Total Assets | 56 | 65 | 83 | 95 | 134 | 138 | 169 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 1 | 2 | 0 | 6 | -7 | -1 | 1 |
| Investing | -1 | -1 | 0 | -3 | -31 | 2 | -28 |
| Financing | 1 | 0 | 5 | -1 | 39 | -7 | 26 |
| Net Cash Flow | 1 | 1 | 5 | 2 | 2 | -6 | -1 |
| Free Cash Flow | 0 | 1 | -1 | 6 | -24 | -6 | -25 |
| CFO/EBITDA | 26 | 39 | 5 | 42 | -62 | -9 | 19 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
| Inventory Days | 31 | 50 | 63 | 70 | 75 | 86 | 78 |
| Days Payable | 19 | 19 | 21 | 18 | 12 | 19 | 16 |
| Cash Conversion Cycle | 13 | 31 | 42 | 53 | 63 | 68 | 63 |
| Working Capital Days | 7 | -2 | -10 | -8 | -2 | 12 | 18 |
| ROCE % | — | 16% | 18% | 26% | 9% | 5% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cell Point insights
59 extracted metrics + investor summaries across FY20–FY26.
Documents
Frequently Asked Questions about Cell Point
What does Cell Point (India) Ltd do?
Where is Cell Point (India) Ltd (CELLPOINT) listed?
Which sector does Cell Point (India) Ltd belong to?
What is the market capitalisation of Cell Point (India) Ltd?
What is the PE ratio of Cell Point (India) Ltd?
What is the 52-week high and low of Cell Point (India) Ltd?
Does Cell Point (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Cell Point (India) Ltd?
Company Information
Incorporated in 2001, Cell Point (India) Ltd trades in smartphones and other consumer durable electronic goods[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CELLPOINT.md for Cell Point (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.